OCDX
Income statement / Annual
Last year (2021), Ortho Clinical Diagnostics Holdings plc's total revenue was $2.04 B,
an increase of 15.66% from the previous year.
In 2021, Ortho Clinical Diagnostics Holdings plc's net income was -$54.30 M.
See Ortho Clinical Diagnostics Holdings plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
01/02/2022 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$2.04 B |
$1.77 B |
$1.80 B |
$1.79 B |
$1.78 B |
| Cost of Revenue |
$1.01 B
|
$908.20 M
|
$922.40 M
|
$930.50 M
|
$897.70 M
|
| Gross Profit |
$1.04 B
|
$858.00 M
|
$879.10 M
|
$856.80 M
|
$884.00 M
|
| Gross Profit Ratio |
0.51
|
0.49
|
0.49
|
0.48
|
0.5
|
| Research and Development Expenses |
$126.20 M
|
$112.90 M
|
$98.00 M
|
$98.70 M
|
$96.40 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$555.00 M
|
$489.60 M
|
$515.10 M
|
$491.60 M
|
$499.80 M
|
| Other Expenses |
$181.70 M
|
$163.10 M
|
$160.90 M
|
$115.70 M
|
$37.90 M
|
| Operating Expenses |
$862.90 M
|
$765.60 M
|
$774.00 M
|
$706.00 M
|
$634.10 M
|
| Cost And Expenses |
$1.87 B
|
$1.67 B
|
$1.70 B
|
$1.64 B
|
$1.53 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$146.00 M
|
$191.10 M
|
$229.30 M
|
$232.50 M
|
$221.70 M
|
| Depreciation & Amortization |
$133.40 M
|
$325.90 M
|
$327.50 M
|
$332.20 M
|
$333.30 M
|
| EBITDA |
$253.40 M |
$291.70 M |
$376.00 M |
$347.10 M |
$540.70 M |
| EBITDA Ratio |
0.12
|
0.17
|
0.21
|
0.19
|
0.3
|
| Operating Income Ratio |
0.06
|
0.05
|
0.05
|
0.04
|
0.02
|
| Total Other Income/Expenses Net |
-$146.00 M
|
-$313.60 M
|
-$266.30 M
|
-$284.10 M
|
-$49.60 M
|
| Income Before Tax |
-$26.00 M
|
-$225.30 M
|
-$180.80 M
|
-$217.60 M
|
-$14.30 M
|
| Income Before Tax Ratio |
-0.01
|
-0.13
|
-0.1
|
-0.12
|
-0.01
|
| Income Tax Expense |
$28.30 M
|
-$13.40 M
|
-$23.90 M
|
$31.20 M
|
$102.00 M
|
| Net Income |
-$54.30 M
|
-$211.90 M
|
-$156.90 M
|
-$248.80 M
|
-$116.30 M
|
| Net Income Ratio |
-0.03
|
-0.12
|
-0.09
|
-0.14
|
-0.07
|
| EPS |
-0.22 |
-0.98 |
-0.71 |
-1.12 |
-0.52 |
| EPS Diluted |
-0.22 |
-0.98 |
-0.71 |
-1.12 |
-0.52 |
| Weighted Average Shares Out |
$242.80 M
|
$216.58 M
|
$221.55 M
|
$222.36 M
|
$221.55 M
|
| Weighted Average Shares Out Diluted |
$242.80 M
|
$216.58 M
|
$221.55 M
|
$222.36 M
|
$221.55 M
|
| Link |
|
|
|
|
|
